183 related articles for article (PubMed ID: 24881343)
1. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study.
Ruiz AD; Daniels KR; Barner JC; Carson JJ; Frei CR
BMC Womens Health; 2011 Jun; 11():27. PubMed ID: 21651797
[TBL] [Abstract][Full Text] [Related]
3. Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women.
Harrington LB; Blondon M; Cushman M; Kaunitz AM; Allison MA; Wang L; Sullivan S; Woods NF; LaCroix AZ; Heckbert SR; McKnight B; Rossouw J; Smith NL
J Thromb Haemost; 2018 May; 16(5):886-892. PubMed ID: 29504242
[TBL] [Abstract][Full Text] [Related]
4. Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial.
Veerus P; Fischer K; Hovi SL; Karro H; Rahu M; Hemminki E
BMC Womens Health; 2008 Mar; 8():5. PubMed ID: 18366766
[TBL] [Abstract][Full Text] [Related]
5. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.
Thompson JJ; Ritenbaugh C; Nichter M
BMC Womens Health; 2017 Oct; 17(1):97. PubMed ID: 28969624
[TBL] [Abstract][Full Text] [Related]
6. Vasomotor symptoms and coronary artery calcium in postmenopausal women.
Allison MA; Manson JE; Aragaki A; Langer RD; Rossouw J; Curb D; Martin LW; Phillips L; Stefanick ML; Cochrane BB; Sarto G; Barnhart J; O'Sullivan MJ; Johnson KC; Gass M; Trevisan M; Woods NF
Menopause; 2010; 17(6):1136-45. PubMed ID: 20651617
[TBL] [Abstract][Full Text] [Related]
7. An ethical assessment of compounded bioidentical hormone therapy.
Kauffman RP; MacLaughlin EJ; Courtney LA; Vineyard DD
Climacteric; 2024 Jun; 27(3):326-328. PubMed ID: 38288691
[TBL] [Abstract][Full Text] [Related]
8. Menopause and hormone-replacement therapy: Part 2. Hormone-replacement therapy regimens.
Ratner S; Ofri D
West J Med; 2001 Jul; 175(1):32-4. PubMed ID: 11431399
[No Abstract] [Full Text] [Related]
9. Fear, misinformation, and pharmaceutical messianism in the promotion of compounded bioidentical hormone therapy.
Kauffman RP; MacLaughlin EJ; Courtney LA; Vineyard DD
Front Reprod Health; 2024; 6():1378644. PubMed ID: 38486847
[TBL] [Abstract][Full Text] [Related]
10. Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5-20% Topical Gels.
Banov D; Biundo B; Ip K; Shan A; Banov F; Song G; Carvalho M
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794283
[TBL] [Abstract][Full Text] [Related]
11. A Recent Review of the Management of Postmenopausal Symptoms in Breast Cancer Survivors.
Kim C; Na Y; Lee S; Park JY; Chung YJ; Song J; Kim MR
J Menopausal Med; 2023 Dec; 29(3):85-91. PubMed ID: 38230591
[TBL] [Abstract][Full Text] [Related]
12. Treating post-menopausal women with symptomatic hand osteoarthritis with hormone replacement therapy.
Baltzer H
Lancet Rheumatol; 2022 Oct; 4(10):e654-e655. PubMed ID: 38265959
[No Abstract] [Full Text] [Related]
13. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
Davis R; Batur P; Thacker HL
J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
[TBL] [Abstract][Full Text] [Related]
14. Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.
Fishman JR; Flatt MA; Settersten RA
Soc Sci Med; 2015 May; 132():79-87. PubMed ID: 25795991
[TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.
Mirkin S; Amadio JM; Bernick BA; Pickar JH; Archer DF
Maturitas; 2015 May; 81(1):28-35. PubMed ID: 25835751
[TBL] [Abstract][Full Text] [Related]
16. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
Deleruyelle LJ
Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
[TBL] [Abstract][Full Text] [Related]
17. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
Pinkerton JV; Santoro N
Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
[TBL] [Abstract][Full Text] [Related]
18. Bioidentical hormones for women with vasomotor symptoms.
Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
[TBL] [Abstract][Full Text] [Related]
19. Treatment of postmenopausal women with topical progesterone creams and gels: are they effective?
Stanczyk FZ
Climacteric; 2014 Dec; 17 Suppl 2():8-11. PubMed ID: 25196424
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
